Nexstim Oyj

5NX

Company Profile

  • Business description

    Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.

  • Contact

    Elimaenkatu 9 B
    Helsinki00510
    FIN

    T: +358 92727170

    https://www.nexstim.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    40

Stocks News & Analysis

stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.
stocks

Nvidia dominance continues

Our view on the latest earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.2015.00-0.17%
CAC 408,115.7529.750.37%
DAX 4024,888.56281.791.15%
Dow JONES (US)50,795.66510.001.01%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,466.31173.220.66%
Nikkei 22563,339.071,654.932.68%
NZX 50 Index12,991.31113.240.88%
S&P 5007,499.6153.890.72%
S&P/ASX 2008,657.0015.10-0.17%
SSE Composite Index4,112.9035.620.87%

Market Movers